Dubocovich M L
J Pharmacol Exp Ther. 1984 Jul;230(1):149-55.
In the rabbit retina, preloaded in vitro with [3H]dopamine, calcium-dependent release of radioactivity was elicited by a 1-min period of field stimulation at 3 Hz (20 mA, 2 msec). In the presence of the catecholamine uptake inhibitor nomifensine (30 microM), unlabeled catecholamines (0.01-3 microM), namely, dopamine, norepinephrine and epinephrine, inhibited in a concentration-dependent manner the field stimulation-evoked release of [3H]dopamine from the retina. The concentrations of dopamine, norepinephrine or epinephrine which inhibited by 50% the release of [3H]dopamine (IC50) were 0.30, 0.25 and 0.25 microM, respectively. In the presence of 30 microM nomifensine, S-sulpiride (1 microM) significantly increased the calcium-dependent release of [3H]dopamine, suggesting that this dopamine antagonist blocks a receptor tonically activated by endogenous dopamine in the rabbit retina. In contrast, the alpha receptor antagonist phentolamine (1 microM) alone did not affect the release of [3H]dopamine from the retina. The inhibitory effect of norepinephrine and epinephrine on [3H]dopamine overflow was not modified by S-sulpiride which, on the contrary, selectively antagonized the effect of exogenous dopamine. Phentolamine (1 microM) competitively antagonized the inhibitory effect of norepinephrine and epinephrine on [3H]dopamine release, suggesting that these catecholamines activate alpha adrenoceptors in retina. In the absence of nomifensine, the selective alpha-2 agonist clonidine (IC50 = 0.056 microM) inhibited the stimulation-evoked release of [3H]dopamine from retina, whereas the alpha agonist methoxamine was without effect. The inhibitory effect of clonidine was antagonized by yohimbine (1 microM), but not prazosin, suggesting that the release modulating alpha receptors of the retina are of the alpha-2 subtype.(ABSTRACT TRUNCATED AT 250 WORDS)
在预先用[3H]多巴胺进行体外加载的兔视网膜中,以3Hz(20mA,2毫秒)进行1分钟的场刺激可引发放射性的钙依赖性释放。在儿茶酚胺摄取抑制剂诺米芬辛(30微摩尔)存在的情况下,未标记的儿茶酚胺(0.01 - 3微摩尔),即多巴胺、去甲肾上腺素和肾上腺素,以浓度依赖性方式抑制视网膜中[3H]多巴胺的场刺激诱发释放。抑制[3H]多巴胺释放50%(IC50)的多巴胺、去甲肾上腺素或肾上腺素浓度分别为0.30、0.25和0.25微摩尔。在30微摩尔诺米芬辛存在的情况下,S-舒必利(1微摩尔)显著增加了[3H]多巴胺的钙依赖性释放,表明这种多巴胺拮抗剂阻断了兔视网膜中由内源性多巴胺持续激活的受体。相反,α受体拮抗剂酚妥拉明(1微摩尔)单独并不影响视网膜中[3H]多巴胺的释放。去甲肾上腺素和肾上腺素对[3H]多巴胺溢出的抑制作用未被S-舒必利改变,相反,S-舒必利选择性地拮抗外源性多巴胺的作用。酚妥拉明(1微摩尔)竞争性拮抗去甲肾上腺素和肾上腺素对[3H]多巴胺释放的抑制作用,表明这些儿茶酚胺激活视网膜中的α肾上腺素能受体。在没有诺米芬辛的情况下,选择性α-2激动剂可乐定(IC50 = 0.056微摩尔)抑制视网膜中刺激诱发的[3H]多巴胺释放,而α激动剂甲氧明则无作用。可乐定的抑制作用被育亨宾(1微摩尔)拮抗,但不被哌唑嗪拮抗,表明视网膜中调节释放的α受体是α-2亚型。(摘要截断于250字)